The University of North Carolina at Chapel Hill

Christophe Salomé

Harold L Kohn

Elise Salomé-Grosjean

Ki Duk Park

A first aspect of the invention is a compound (sometimes also referred to herein as an 'active agent' or 'active compound') of Formula I or Ia: or a pharmaceutically acceptable salt or prodrug thereof. Compositions thereof and methods of using the same (e.g. for the treatment of a neurological disease) are also described.

N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents

A first aspect of the invention is a compound (sometimes also referred to herein as an 'active agent' or 'active compound') of Formula Ia, or more particularly Formula Ib, or a pharmaceutically acceptable salt or prodrug thereof. Compositions thereof and methods of using the same (e.g. for the treatment of a neurological disease) are also described. 

Growing community of inventors

Herrlisheim-prés-Colmar, France

Christophe Salomé